Adyen and medicalforce Unite to Simplify In-Clinic Payments with One-Click Integration

Adyen and medicalforce Unite to Simplify In-Clinic Payments with One-Click Integration

(IN BRIEF) Adyen has been chosen by medicalforce Inc. to add in-person POS payments to its all-in-one clinic management SaaS. Previously limited to online credit-card transactions, medicalforce’s platform will now send invoice amounts directly to Adyen terminals via a single API call, automating accounting entries and reducing human error. Clinics gain one-click payment processing and centralized transaction histories within their EMR dashboard. The integration leverages Adyen’s rapid deployment, robust security features, and global implementation record. Next steps include enhancing online payments and expanding terminal deployments across dermatology, plastic surgery, and cosmetic clinics in Japan.

(PRESS RELEASE) AMSTERDAM, 2-Jul-2025 — /EuropaWire/ — Adyen, the global fintech platform trusted by leading enterprises, today announces its partnership with medicalforce Inc., provider of the all-in-one SaaS solution “medicalforce” for clinics. By integrating Adyen’s POS terminals directly into medicalforce’s accounting module, clinics can now process in-person credit-card payments with a single click—automatically linking transaction data to patient records and eliminating manual entry errors.

Designed primarily for dermatology, plastic surgery, and cosmetic surgery practices, medicalforce streamlines every aspect of clinic operations—from electronic medical records and appointment scheduling to inventory and financial management. Already adopted by over 550 clinics nationwide and ranked No. 1 in usage as an EMR system*, medicalforce previously supported only online payments via pre-registered credit cards, requiring staff to manually reconcile payments.

Seeking a seamless in-clinic payment experience, medicalforce evaluated Adyen and chose its platform for four key advantages:

  • Effortless API integration: Quick, reliable connection with minimal development overhead
  • Rapid deployment: Accelerated testing and go-live timelines
  • Enterprise-grade security: Advanced fraud detection critical for high-value medical transactions
  • Proven global footprint: A robust track record of deployments in Japan and worldwide

With the new integration, staff send the exact invoice amount from medicalforce to the POS terminal in one step, reducing input time and virtually eliminating transcription mistakes. Full payment histories remain accessible within the medicalforce dashboard, centralizing financial oversight and simplifying reconciliation.

Looking ahead, medicalforce Inc. plans to leverage Adyen’s platform to enhance its online payment capabilities and roll out terminal payments to even more dermatology and cosmetic clinics across Japan.

“By listening to on-site teams, we identified a need for secure, in-person card processing,” says Shoichi Hatanaka, CEO of medicalforce Inc. “Together with Adyen, we’ve built a solution that boosts reliability and usability, further reducing administrative burdens and optimizing clinic management.”

Adam Brownstein, Japan Country Manager for Adyen, adds, “We’re thrilled to support medicalforce’s mission to modernize clinic workflows. Our easy-to-integrate POS APIs and extensive deployment experience made Adyen the ideal choice. We look forward to continuing to streamline medical payments throughout Japan.”

About Adyen

Adyen (AMS: ADYEN) is the financial technology platform of choice for leading companies. By providing end-to-end payments capabilities, data-driven insights, and financial products in a single global solution, Adyen helps businesses achieve their ambitions faster. With offices around the world, Adyen works with the likes of Meta, Uber, H&M, eBay, and Microsoft. The cooperation with medicalforce Inc. as described in this press release, underlines Adyen’s continuous growth with existing and new customers over the years.

Media Contact:

email: press@adyen.com

SOURCE: Adyen NV

MORE ON ADYEN, ETC.:
EDITOR'S PICK:

Comments are closed.